Brind.

Akebia Therapeutics is providing Vafseo for kidney disease treatment, which Innovative Renal Care has made available across all clinics.

6 reports, 2 independent Updated Aug 21
Gone quiet Reached 2 outlets in its first 24 hours
Reports
6
Developments
5
Repetition
33%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 2 outlets

Akebia Therapeutics is providing Vafseo for kidney disease treatment, which Innovative Renal Care has made available across all clinics.

Who's involved

What this event is mainly about
Akebia Therapeutics (United States)

How it developed

Newest first. Tap a step to see who reported it.
  1. DaVita is starting an operational pilot for Vafseo, and Akebia expects IRC to operationalize the Vafseo protocols.Sub-event
  2. Product Vafseo for kidney disease is now available through Innovative Renal Care clinics.1 source
  3. Revenue surge driven by strong sales of Vafseo and Auryxia.1 source
  4. FDA approved Vafseo for CKD anemia treatment; Akebia also benefits from Trump tariffs.1 source
  5. FDA approved vadadustat for chronic kidney disease treatment.

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped
  • GlobeNewswireAkebia Therapeutics and Innovative Renal Care Announce Nationwide Availability of Vafseo® (vadadustat) Across All IRC Dialysis Clinics CAMBRIDGE, Mass. and FRANKLIN, Tenn., Aug. 21, 2025 (GLOBE NEWSW
  • Insider MonkeyAkebia Therapeutics (AKBA) Bounces to Profitability amid Kidney Treatment Growth Akebia Therapeutics, Inc. (NASDAQ:AKBA) is one of the best multibagger penny stocks to buy according to analysts. On A
  • Insider MonkeyH.C. Wainwright Rates Akebia Therapeutics (AKBA) Stock Buy Akebia Therapeutics, Inc. (NASDAQ:AKBA) is one of the 10 Best Performing Penny Stocks So Far in 2025. On June 4, H.C. Wainwright analysts in
  • Insider MonkeyAkebia Therapeutics (AKBA) Kidney Therapy Vafseo Gaining Market Share Akebia Therapeutics, Inc. (NASDAQ:AKBA) is one of the best high-return penny stocks to buy now. On July 14, 2025, Akebia shared k
  • Unknown outlet
  • Unknown outlet